Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Industry / Czech Republic

Zentiva Expands Eastwards

October 2007 | Industry News

Czech drugmaker Zentiva recorded a disappointing performance on its home market in H107 with sales receding 5.6% to CZK2,226mn (US$115.08mn). Chief Financial Officer Petr Sulc blames recent drug market reforms, which have impacted volume sales.

To read the full article, please choose one of the following options:

Subcribers please log in

Emerging Europe InsightEmerging Europe Channels Emerging Europe Countries